Cargando…

Common Shortcomings in Study on Radiopharmaceutical Design Research: A Case Study of (99m)Tc-Labelled Methotrexate

The aim of the work carried out was to draw attention to shortcomings that often appear at the stage of designing new radiopharmaceuticals. Based on a case study of (99m)Tc-labelled methotrexate, this article describes frequent mistakes or misconceptions present not only in the referenced studies, b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koźmiński, Przemysław, Halik, Paweł Krzysztof, Chesori, Raphael, Gniazdowska, Ewa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510358/ https://www.ncbi.nlm.nih.gov/pubmed/34641406 http://dx.doi.org/10.3390/molecules26195862

Ejemplares similares

Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers
por: Koźmiński, Przemysław, et al.
Publicado: (2020)

Physicochemical and Biological Study of (99m)Tc and (68)Ga Radiolabelled Ciprofloxacin and Evaluation of [(99m)Tc]Tc-CIP as Potential Diagnostic Radiopharmaceutical for Diabetic Foot Syndrome Imaging
por: Koźmiński, Przemysław, et al.
Publicado: (2021)

Perspectives of Methotrexate-Based Radioagents for Application in Nuclear Medicine
por: Halik, Paweł Krzysztof, et al.
Publicado: (2020)

Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with (99m)Tc and (177)Lu as Potential Receptor Radiopharmaceuticals
por: Majkowska-Pilip, Agnieszka, et al.
Publicado: (2018)

In Vitro Evaluation of Tc-99m Radiopharmaceuticals for Gastric Emptying Studies
por: Ertay, Türkan, et al.
Publicado: (2014)

Radiochemical Synthesis and Evaluation of Novel Radioconjugates of Neurokinin 1 Receptor Antagonist Aprepitant Dedicated for NK1R-Positive Tumors
por: Halik, Paweł K., et al.
Publicado: (2020)

In Vitro Biological Evaluation of Aprepitant Based (177)Lu-Radioconjugates
por: Halik, Paweł K., et al.
Publicado: (2022)

Radiosynthesis, quality control, biodistribution, and infection-imaging study of a new (99m)Tc-labeled ertapenem radiopharmaceutical
por: Naqvi, Syed Ali Raza, et al.
Publicado: (2022)

Influence of Storage Temperature on Radiochemical Purity of (99m)Tc-Radiopharmaceuticals
por: Uccelli, Licia, et al.
Publicado: (2018)

Novel NK1R-Targeted (68)Ga-/(177)Lu-Radioconjugates with Potential Application against Glioblastoma Multiforme: Preliminary Exploration of Structure–Activity Relationships
por: Matalińska, Joanna, et al.
Publicado: (2022)

Synthesis, Physicochemical and Biological Study of Gallium-68- and Lutetium-177-Labeled VEGF-A(165)/NRP-1 Complex Inhibitors Based on Peptide A7R and Branched Peptidomimetic
por: Masłowska, Katarzyna, et al.
Publicado: (2022)

Comparison of the Absorbed Dose for (99m)Tc-Diethylenetriaminepentaacetic Acid and (99m)Tc-Ethylenedicysteine Radiopharmaceuticals using Medical Internal Radiation Dosimetry
por: Pirdamooie, Shokufeh, et al.
Publicado: (2015)

Mathematical Simulation of Transport Kinetics of Tumor-Imaging Radiopharmaceutical (99m)Tc-MIBI
por: Shevtsova, O. N., et al.
Publicado: (2017)

New Imaging Modality of COVID-19 Pneumonia Developed on the Basis of Alzheimer’s Disease Research
por: Koźmiński, Przemysław, et al.
Publicado: (2022)

The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy
por: Majkowska-Pilip, Agnieszka, et al.
Publicado: (2019)

Alternative chromatographic system for the quality control of lipophilic technetium-99m radiopharmaceuticals such as [(99m)Tc(MIBI)(6)](+)
por: Faria, D.P., et al.
Publicado: (2015)

Radiopharmaceutical supply disruptions and the use of (99m)Tc-hydroxymethylene diphosphonate as an alternative to (99m)Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement
por: Miller, Edward J., et al.
Publicado: (2022)

Labeling and Biological Evaluation of (99m)Tc-HYNIC-Trastuzumab as a Potential Radiopharmaceutical for In Vivo Evaluation of HER2 Expression in Breast Cancer
por: Calzada, Victoria, et al.
Publicado: (2013)

Radiation Levels from Toilets Used By Patients Injected with 99mTc-based Radiopharmaceuticals in Ibadan
por: Ejeh, John Enyi, et al.
Publicado: (2014)

Sorbitol as a Polar Pharmacological Modifier to Enhance the Hydrophilicity of (99m)Tc-Tricarbonyl-Based Radiopharmaceuticals
por: Giammei, Carolina, et al.
Publicado: (2020)

Dose-Dependent Internalization and Externalization Integrity Study of Newly Synthesized (99m)Tc-Thymoquinone Radiopharmaceutical as Cancer Theranostic Agent
por: Tariq, Saima, et al.
Publicado: (2020)

An Overview of In Vitro Assays of (64)Cu-, (68)Ga-, (125)I-, and (99m)Tc-Labelled Radiopharmaceuticals Using Radiometric Counters in the Era of Radiotheranostics
por: Benfante, Viviana, et al.
Publicado: (2023)

The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy
por: Masłowska, Katarzyna, et al.
Publicado: (2021)

Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO
por: de Vries, Erik F. J., et al.
Publicado: (2010)

Biodistribution of (99m)Tc Labeled Integrin Antagonist
por: Jang, Beom-Su, et al.
Publicado: (2013)

(99m)Tc Glucarate as a Potential Radiopharmaceutical Agent for Assessment of Tumor Viability: From Bench to the Bed Side
por: Choudhury, Partha S., et al.
Publicado: (2012)

Estimating the Absorbed Dose of Organs in Pediatric Imaging of (99m)Tc-DTPATc-DTPA Radiopharmaceutical using MIRDOSE Software
por: K., Ebrahimnejad Gorji, et al.
Publicado: (2019)

(99m)Tc-besilesomab (Scintimun®) in peripheral osteomyelitis: comparison with (99m)Tc-labelled white blood cells
por: Richter, Wolf S., et al.
Publicado: (2011)

Synthesis and In Vitro Evaluation of Gold Nanoparticles Functionalized with Thiol Ligands for Robust Radiolabeling with (99m)Tc
por: Apostolopoulou, Adamantia, et al.
Publicado: (2021)

(99m)tc-Ubiquicidin [29–41], a Promising Radiopharmaceutical to Differentiate Orthopedic Implant Infections from Sterile Inflammation
por: Beiki, Davood, et al.
Publicado: (2013)

Quality Assessment of Tc-99m Methylene Diphosphonate (MDP) Radiopharmaceutical Prepared Using Different Cold Kit Fractionation Methods
por: Thokchom, Arun Kumar, et al.
Publicado: (2022)

Development of Nanoradiopharmaceuticals by Labeling Polymer Nanoparticles with Tc-99m
por: Patricio, B. F. de Carvalho, et al.
Publicado: (2013)

Erratum to: Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO
por: de Vries, Erik F. J., et al.
Publicado: (2010)

(99m)Tc-labeled nanocolloid drugs: development methods
por: Sadkin, Vladimir, et al.
Publicado: (2020)

Recombinant Complement Receptor 2 Radiolabeled with [(99m)Tc(CO)(3)](+) : A Potential New Radiopharmaceutical for Imaging Activated Complement
por: Badar, Adam, et al.
Publicado: (2011)

Synthesis and Biological Evaluation of Pyrazolo[1,5-a]-pyrimidine-containing (99m)Tc Nitrido Radiopharmaceuticals as Imaging Agents for Tumors
por: Ding, Rui, et al.
Publicado: (2010)

One-step, kit-based radiopharmaceuticals for molecular SPECT imaging: a versatile diphosphine chelator for (99m)Tc radiolabelling of peptides
por: Hungnes, Ingebjørg N., et al.
Publicado: (2021)

Evaluation of Annual Staff Doses and Radiation Shielding Efficiencies of Thyroid Shield and Lead Apron during Preparation and Administration of (131)I, (81)Kr, and (99m)Tc-Labeled Radiopharmaceuticals
por: Khalili, Nayereh, et al.
Publicado: (2021)

An efficient method for the site-specific (99m)Tc labeling of nanobody
por: Luo, Qi, et al.
Publicado: (2021)

Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis
por: Rauf, Muhammad Umaid, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kn16nrn7oifubabg1df0dutjcp